- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Stereotactic radiotherapy combined with immune- or targeted therapy for metastatic renal cell carcinoma.
October 29, 2020
Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma.
October 28, 2020
Organotypic primary blood vessel models of clear cell renal cell carcinoma for single-patient clinical trials.
October 28, 2020
Differentiation of renal cell tumors with morphological cocktails using a minimal panel of immunohistochemical markers.
October 28, 2020
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE).
October 28, 2020
Suppressive effects of RASAL2 on renal cell carcinoma via SOX2/ERK/p38 MAPK pathway.
October 27, 2020
Transplant Radical Nephrectomy and Transplant Radical Nephroureterectomy for Renal Cancer: Postoperative and Survival Outcomes.
October 26, 2020
Dynamic 68Ga-PSMA-11 PET/CT for the primary evaluation of localized renal mass: a prospective study.
October 26, 2020
HIF1α is not a target of 14q deletion in clear cell renal cancer.
October 22, 2020
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
October 22, 2020
Folliculin deficient renal cancer cells exhibit BRCA1 A complex expression impairment and sensitivity to PARP1 inhibitor olaparib.
October 22, 2020
Robot-assisted retroperitoneal lymphadenectomy in patient with type I papillary renal cancer recurrence after 5 years of follow-up.
October 21, 2020
Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy.
October 21, 2020